Literature DB >> 4152780

Anti-inflammatory property of 401 (MCD-peptide), a peptide from the venom of the bee Apis mellifera (L.).

J M Hanson, J Morley, C Soria-Herrera.   

Abstract

1 Peptide 401, a potent mast cell degranulating factor from bee venom, substantially inhibited the oedema provoked by subplantar injection of carrageenin or intra-articular injection of turpentine in the rat. The ED(50) of 401 was c. 0.1 mg/kg. The anti-inflammatory effect was assessed by measurement of the increased (125)I-albumin content of an injected site in comparison with an uninjected contralateral site.2 Peptide 401 also suppressed the increased vascular permeability due to intradermal injection of various smooth muscle spasmogens (histamine, bradykinin, 5-hydroxytryptamine (5-HT), and prostaglandins).3 Other comparable mast cell degranulating agents (48/80 and melittin) showed little evidence of anti-inflammatory activity when tested at comparable dosage on turpentine arthritis and carrageenin oedema.4 The anti-inflammatory effects were not abolished by pretreatment with mepyramine and methysergide, which abolished the increased vascular permeability produced by local injection of 401.5 The anti-inflammatory action of 401 was not affected by regional denervation or pretreatment with phenoxybenzamine, and was reduced but not abolished by adrenalectomy.6 Measurement of skin temperature, fractional extraction of (86)Rb and blood flow in perfused mesentery gave no evidence that the anti-inflammatory action of 401 was due to reduced tissue perfusion.7 It is concluded that 401 may exert its anti-inflammatory action directly by making the vascular endothelium anergic to phlogistic stimuli.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4152780      PMCID: PMC1776661          DOI: 10.1111/j.1476-5381.1974.tb09613.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Letter: An anti-inflammatory peptide from bee venom.

Authors:  M E Billingham; J Morley; J M Hanson; R A Shipolini; C A Vernon
Journal:  Nature       Date:  1973-09-21       Impact factor: 49.962

2.  [MCD-peptide from bee venom: isolation, biochemical and pharmacolgical properties].

Authors:  H Breithaupt; E Habermann
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

3.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

4.  Effects of prostaglandins PGF2a and PGE1 on vascular permeability.

Authors:  D A Willoughby
Journal:  J Pathol Bacteriol       Date:  1968-10

5.  [Amino acid sequence of MCD-peptide, a specific mast cell-degranulating peptide from bee venom].

Authors:  P Haux
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1969-05

6.  Anti-inflammatory properties of alkyl-pseudothioureas with antibacterial and antifungal activity.

Authors:  N Ercoli; J Arbona; E Tabernero
Journal:  Proc Soc Exp Biol Med       Date:  1971-04

7.  [On the biochemistry of bee venom peptides, melittin and apamin].

Authors:  E Habermann; K G Reiz
Journal:  Biochem Z       Date:  1965-11-15

8.  Prostaglandin E 1 (PGE 1 ) suppression of adjuvant arthritis. Histopathology.

Authors:  R B Zurier; M Ballas
Journal:  Arthritis Rheum       Date:  1973 Mar-Apr

9.  PRESENCE OF KALLIKREIN IN THE GAMMA-GLOBULIN PERMEABILITY FACTOR OF GUINEA-PIG SERUM.

Authors:  G E DAVIES; J S LOWE
Journal:  Br J Pharmacol Chemother       Date:  1963-12

10.  Vascular resistance in the perfused isolated rat tail.

Authors:  D N Wade; L J Beilin
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

  10 in total
  9 in total

1.  Antiarthritic activity of majoon suranjan (a polyherbal Unani formulation) in rat.

Authors:  Surender Singh; Vinod Nair; Y K Gupta
Journal:  Indian J Med Res       Date:  2011-09       Impact factor: 2.375

2.  Histamine releasing and anti-inflammatory activities of MCD-peptide and its modified forms.

Authors:  I S Gushchin; A I Miroshnikov; V I Martynov; V V Sviridov
Journal:  Agents Actions       Date:  1981-04

3.  Therapeutic effect of umbelliferon-α-D-glucopyranosyl-(2(I)→1(II))-α-D-glucopyranoside on adjuvant-induced arthritic rats.

Authors:  Vikas Kumar; Firoz Anwar; Amita Verma; Mohd Mujeeb
Journal:  J Food Sci Technol       Date:  2014-05-11       Impact factor: 2.701

4.  Therapeutic effect of Linum usitatissimum (flaxseed/linseed) fixed oil on acute and chronic arthritic models in albino rats.

Authors:  Gaurav Kaithwas; Dipak K Majumdar
Journal:  Inflammopharmacology       Date:  2010-02-16       Impact factor: 4.473

5.  Mast cell degranulating (MCD) peptide analogs with reduced ring structure.

Authors:  A Buku; J Reibman; A Pistelli; P Blandina; D Gazis
Journal:  J Protein Chem       Date:  1992-06

6.  Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo.

Authors:  B E Banks; C E Dempsey; C A Vernon; J A Warner; J Yamey
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

7.  Anti-arthritic effect of bee venom.

Authors:  Y H Chang; M L Bliven
Journal:  Agents Actions       Date:  1979-06

Review 8.  Bee Venom: Overview of Main Compounds and Bioactivities for Therapeutic Interests.

Authors:  Rim Wehbe; Jacinthe Frangieh; Mohamad Rima; Dany El Obeid; Jean-Marc Sabatier; Ziad Fajloun
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

9.  Anti-arthritic activity of aqueous-methanolic extract and various fractions of Berberis orthobotrys Bien ex Aitch.

Authors:  Ambreen Malik Uttra; Umme Habiba Hasan
Journal:  BMC Complement Altern Med       Date:  2017-07-18       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.